Skip to content
healthcare.dev
Get a free key

Griseofulvin

NDC 0472-0013, Griseofulvin, suspension, from Actavis Pharma, Inc..

Product NDC
0472-0013
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA065394
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0472-0013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GRISEOFULVIN125 mg/5mL

Pharmacologic classes

Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]

Package NDCNDC-11Package
0472-0013-0400472001304120 mL in 1 BOTTLE (0472-0013-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/af318d5d-cc39-4a63-a590-b87c50f2694f

  • NADAC price for package 00472001304

    GET /v1/drugs/nadac/00472001304

Use it

Look up 0472-0013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0472-0013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0472-0013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.